Continuous cell lines as a production system for influenza vaccines
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Continuous cell lines as a production system for influenza vaccines
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 8, Issue 12, Pages 1681-1692
Publisher
Informa UK Limited
Online
2009-11-28
DOI
10.1586/erv.09.128
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FluBlok, a next generation influenza vaccine manufactured in insect cells
- (2009) Manon M.J. Cox et al. BIOLOGICALS
- Trivalent MDCK cell culture-derived influenza vaccine Optaflu®(Novartis Vaccines)
- (2009) Alexander Doroshenko et al. Expert Review of Vaccines
- Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines
- (2009) P Noel Barrett et al. Expert Review of Vaccines
- Subunit Influenza Vaccines Produced from Cell Culture or in Embryonated Chicken Eggs: Comparison of Safety, Reactogenicity, and Immunogenicity
- (2009) Keith S. Reisinger et al. JOURNAL OF INFECTIOUS DISEASES
- A Cell Culture (Vero)–Derived H5N1 Whole‐Virus Vaccine Induces Cross‐Reactive Memory Responses
- (2009) Hartmut J. Ehrlich et al. JOURNAL OF INFECTIOUS DISEASES
- Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines
- (2009) Diana Vester et al. PROTEOMICS
- Suitability of PER.C6® cells to generate epidemic and pandemic influenza vaccine strains by reverse genetics
- (2009) W. Koudstaal et al. VACCINE
- Use of MDCK cells for production of live attenuated influenza vaccine
- (2009) Jonathan Liu et al. VACCINE
- Glycan analysis in cell culture-based influenza vaccine production: Influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin
- (2009) Jana Schwarzer et al. VACCINE
- Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production—Flow cytometry and mathematical modeling
- (2009) J. Schulze-Horsel et al. VACCINE
- New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: Studies on growth, metabolism and virus propagation
- (2009) V. Lohr et al. VACCINE
- Current challenges in implementing cell-derived influenza vaccines: Implications for production and regulation, July 2007, NIBSC, Potters Bar, UK
- (2009) Philip D. Minor et al. VACCINE
- A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine
- (2009) Rebecca J. Cox et al. VACCINE
- Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines
- (2008) M. Keith Howard et al. BIOLOGICAL CHEMISTRY
- Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials)
- (2008) Larisa Rudenko et al. Influenza and Other Respiratory Viruses
- Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza
- (2008) Christopher S. Ambrose et al. Influenza and Other Respiratory Viruses
- MDCK-SIAT1 Cells Show Improved Isolation Rates for Recent Human Influenza Viruses Compared to Conventional MDCK Cells
- (2008) D. Y. Oh et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The human H5N1 influenza A virus polymerase complex is active in vitro over a broad range of temperatures, in contrast to the WSN complex, and this property can be attributed to the PB2 subunit
- (2008) B. G. Bradel-Tretheway et al. JOURNAL OF GENERAL VIROLOGY
- H5N1 Avian Influenza Virus Induces Apoptotic Cell Death in Mammalian Airway Epithelial Cells
- (2008) T. Daidoji et al. JOURNAL OF VIROLOGY
- Growth Determinants for H5N1 Influenza Vaccine Seed Viruses in MDCK Cells
- (2008) S. Murakami et al. JOURNAL OF VIROLOGY
- A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines
- (2008) Jens-Peter Gregersen VACCINE
- A quantitative risk assessment of exposure to adventitious agents in a cell culture-derived subunit influenza vaccine
- (2008) Jens-Peter Gregersen VACCINE
- Timely production of A/Fujian-like influenza vaccine matching the 2003–2004 epidemic strain may have been possible using Madin–Darby canine kidney cells
- (2008) Keiichi Makizumi et al. VACCINE
- Canine MDCK cell lines are refractory to infection with human and mouse prions
- (2008) Magdalini Polymenidou et al. VACCINE
- High titer growth of human and avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases
- (2008) Kristen A. Smith et al. VACCINE
- Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines
- (2008) Alan Yung-Chih Hu et al. VACCINE
- An avian cell line designed for production of highly attenuated viruses
- (2008) Ingo Jordan et al. VACCINE
- Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: A sequential Phase I and Phase II clinical trial
- (2008) N. Groth et al. VACCINE
- Maturation efficiency of viral glycoproteins in the ER impacts the production of influenza A virus
- (2008) Mayo Ueda et al. VIRUS RESEARCH
- Purification and cDNA cloning of a novel protease inhibitor secreted into culture supernatant by MDCK cells
- (2007) Kiyoto Nishiyama et al. BIOLOGICALS
- Establishment of Higher Passage PER.C6 Cells for Adenovirus Manufacture
- (2007) M. Berdichevsky et al. BIOTECHNOLOGY PROGRESS
- The potential of a protease activation mutant of a highly pathogenic avian influenza virus for a pandemic live vaccine
- (2007) G. Gabriel et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search